Neurokinin-1 enables measles virus trans-synaptic spread in neurons

Virology

Volumn 362, Issue 1, 2007, Pages 235-244

  Makhortova, Nina R ^a   Askovich, Peter ^a   Patterson, Catherine E ^a   Gechman, Lisa A ^a   Gerard, Norma P ^b   Rall, Glenn F ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CD46; Central nervous system; Fusion; Fusion inhibitory peptide; Measles; Neurokinin 1; Neuron; Spread; Subacute sclerosing panencephalitis; Substance P

Indexed keywords

ENVELOPE PROTEIN; HEMAGGLUTININ; NEUROKININ; NEUROKININ 1; NEUROTRANSMITTER; SUBSTANCE P; SUBSTANCE P RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; FIBROBLAST; GENE DELETION; MEASLES VIRUS; NERVE CELL; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS TRANSMISSION;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; MEASLES; MEASLES VIRUS; MICE; MICE, KNOCKOUT; NEURONS; NEUROTRANSMITTER AGENTS; RECEPTORS, NEUROKININ-1; RECEPTORS, VIRUS; SURVIVAL ANALYSIS; VERO CELLS; VIRAL FUSION PROTEINS;

MEASLES VIRUS; MORBILLIVIRUS; MUS;

EID: 34247261574     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.02.033     Document Type: Article

References (38)

1. Anlar B. SSPE: diagnosis and drug treatment options. CNS Drugs 7 (1997) 111-120
2. Banker G., and Goslin K. Culturing Nerve Cells (1991), MIT Press, Cambridge
3. Bozic C.R., Lu B., Hopken U.E., Gerard G., and Gerard N.P. Neurogenic amplification of immune complex inflammation. Science 273 (1996) 1722-1725
4. Cathomen T., Naim H.Y., and Cattaneo R. Measles virus with altered envelope protein cytoplasmic tails gain fusion competence. J. Virol. 72 (1998) 1224-1234
5. Cattaneo R. Four viruses, two bacteria and one receptor: membrane co-factor protein (CD46) as pathogens' magnet. J. Virol. 78 (2004) 4385-4388
6. Dorig R.E., Marcil A., Chopra A., and Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75 (1993) 295-305
7. Dutch R.E., Hagglund R.N., Nagel M.A., Peterson R.G., and Lamb R.A. Paramyxovirus fusion protein: a conformational change on cleavage activation. Virology 281 (2001) 138-150
8. Gerard N.P., Garraway L.A., Eddy R.L., Shows T.B., Ijima H., Paquet J.L., and Gerard C. Human substance P receptor (NK-1): organization of the gene, chromosome localization and functional expression of cDNA clones. Biochemistry 30 (1991) 10640-10646
9. Griffin D.E., and Bellini W.J. Measles virus. In: Knipe D.M., Fields B.N., Howley P.M., et al. (Eds). Fields Virology (1996), Lippincott-Raven, Philadelphia, PA 1267-1312
10. Harrowe G., Mitsuhashi M., and Payan D.G. Measles virus-Substance P receptor interactions: possible novel mechanism of viral fusion. J. Clin. Invest. 85 (1990) 1324-1327
11. Horvath C.M., Paterson R.G., Shaughnessy M.A., Wood R., and Lamb R.A. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J. Virol. 66 (1992) 4564-4569
12. Hu X.L., Ray R., and Compans R.W. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J. Virol. 66 (1992) 1528-1534
13. Ito M., Nishio M., Kawano M., Kusagawa S., Komada H., Ito Y., and Tsurudome M. Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation. J. Virol. 71 (1997) 9855-9858
14. Katz M. Clinical spectrum of measles. Curr. Top. Microbiol. Immunol. (1995) 1-10
15. Kelsey D.R., Flanagan T.D., Young J.E., and Yeagle P.L. Inhibition of Sendai virus fusion with phospholipid vesicles and human erythrocyte membranes by hydrophobic peptides. Virology 182 (1991) 690-702
16. Lawrence D.M.P., Vaughn M.M., Belman A.R., Cole J.S., and Rall G.F. Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and CNS disease. J. Virol. 73 (1999) 1795-1801
17. Lawrence D.M.P., Patterson C.E., Gales T.L., D'Orazio J.L., Vaughn M.M., and Rall G.F. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation or extracellular virus production. J. Virol. 74 (2000) 1908-1918
18. Mantyh P.W. Neurobiology of substance P and the NK1 receptor. J. Clin. Psychiatry 63 (2002) 6-10
19. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., and Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67 (1993) 6025-6032
20. Norrby E. The effect of a carbobenzoxy tripeptide on the biological activities of measles virus. Virology 44 (1971) 599-608
21. Oldstone M.B.A., Lewicki H., Thomas D., Tishon A., Dales S., Patterson J., Manchester M., Homann D., Naniche D., and Holz A. Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98 (1999) 629-640
22. Pasick J.M., Kalicharran K., and Dales S. Distribution and trafficking of JHM coronavirus structural proteins and virions in primary neurons and the OBL-21 neuronal cell line. J. Virol. 68 (1994) 2915-2928
23. Paterson R.G., Russell C.J., and Lamb R.A. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology 270 (2000) 17-30
24. Patterson C.E., Lawrence D.M., Echols L.A., and Rall G.F. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma-interferon dependent. J. Virol. 76 (2002) 4497-4506
25. Payan D.G., Brewster D.R., Missirian-Bastian A., and Goetzl E.A. Substance P recognition by a subset of human T lymphocytes. J. Clin. Invest. 74 (1984) 1532-1539
26. Payne F.E., Baublis J.V., and Itabashi H.H. Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. N. Engl. J. Med. 281 (1969) 585-589
27. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., and Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci. 74 (2004) 1445-1463
28. Rall G.F., Mucke L., and Oldstone M.B.A. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex-expressing neurons in vivo. J. Exp. Med. 182 (1995) 1201-1212
29. Rall G.F., Manchester M., Daniels L.R., Callahan E.M., Belman A.R., and Oldstone M.B.A. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4659-4663
30. Richardson C.D., and Choppin P.W. Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology 131 (1983) 518-532
31. Richardson C.D., Scheid A., and Choppin P.W. Specific inhibition of paramyxovirus replication by oligopeptides with amino acid sequences similar to those at the N-terminus of the F1 or HA2 viral polypeptides. Virology 105 (1980) 205-222
32. Sarntinoranont M., Iadarola M.J., and Morrison P.F. A kinetic analysis of substance P trafficking. J. Pharm. Sci. 92 (2003) 232-243
33. Schaffer M., Beiter T., Becker H.D., and Hunt T.K. Neuropeptides: mediators of inflammation and tissue repair?. Arch. Surg. 133 (1998) 1116-1607
34. Schendler J., Zimmer G., Herrler G., and Conzelmann K.K. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection. J. Virol. 77 (2003) 4609-4616
35. Schneider-Schaulies J., Niewiesk S., Schneider-Schaulies S., Meulen V., and ter. Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J. Neuroimmunol. 5 (1999) 613-622
36. Schroeder C. Substance P, a neuropeptide, inhibits measles virus replication in cell culture. Acta Virol. 30 (1986) 432-436
37. Techaarpornkul S., Barretto N., and Peeples M.E. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J. Virol. 75 (2001) 6825-6834
38. Zimmer G., Rohn M., McGregor G.P., Schemann M., Conzelmann K.K., and Herrler G. Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of BRSV. J. Biol. Chem. 278 (2003) 46854-46861